Infection Surveillance Solutions Market
Infection Surveillance Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Offering (Software, Services); By Infection Type (Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI)); By End Use (Long Term Care Facilities, Hospitals); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: February 2023
- Report ID: BWC23157
- Available Format: PDF
- Page: 400
Report Overview
Growing adoption of antimicrobial stewardship programs and rapid advancements in healthcare IT addressing infectious therapeutic segment are projected to propel the expansion of global infection surveillance solutions market during the forecast period between 2023 and 2029.Global Infection Surveillance Solutions Market - Industry Trends & Forecast Report, 2029
Global infection surveillance solutions market size was estimated at USD 469.91 million in 2022. During the forecast period between 2023 and 2029, the size of global infection surveillance solutions market is projected to grow at a CAGR of 13.81% reaching a value of USD 1,152.12 million by 2029. Major growth drivers for global infection surveillance solutions market include growing prevalence of hospital-acquired infections (HAIs), increasing antibiotic resistance in microorganisms, and high adoption of automation in healthcare settings. The growing number of procedures conducted around the world has resulted in longer hospital stays. As a result, the number of patients suffering from HAIs is expected to rise. The increasing focus on containing HAIs and treating the patients affected by them is expected to aid the market growth. Increasing healthcare spending is also forecast to increase demand for infection surveillance technologies. Also, favorable government measures will contribute to the market expansion.
Global Infection Surveillance Solutions Market – Overview
Infection monitoring software supports healthcare facilities, such as hospitals and others in reporting patient data to state and federal authorities. This program notifies hospital Internet Protocol (IPs) when an infection occurs, allowing HAI specialists and nurses to treat infected patients and prevent infection epidemics. These solutions are used to identify infections as well as to evaluate prevention actions. They are also required to avoid infections caused by sterilized medical devices and to diagnose antibiotic-resistant organisms. These systems benefit healthcare facilities by providing accurate staff health information, surgical databases, and real-time medical records. Surveillance strategies are employed to control infection patterns. The increasing analytics capabilities of IT systems is assisting the market's growth. Hospitals have emerged as the primary end-user in these sectors due to their high adoption rate for preserving electronic healthcare data and managing real-time pharmacy. Infection monitoring systems are meant to continuously monitor and analyze health-related data to ensure that preventive actions are properly applied. Hospital-acquired illnesses, also known as nosocomial infections, are caused by a variety of factors, including poor hygienic conditions, neglect, weakened patient immunity, the invasion of drug-resistant bacteria, and procedures that can reduce the effectiveness of ongoing treatments.
Global Infection Surveillance Solutions Market
Growth Drivers
Growing Adoption of Antimicrobial Stewardship Programs
Infection Control and Epidemiology are working hard to reduce the rising number of HAIs. Antimicrobial resistance (AMR) is a global danger to human health and development. AMR was named one of the top ten global public health dangers confronting humanity by the WHO. According to the WHO 2020 study, the global economic burden of AMR is enormous. Aside from mortality and incapacity, prolonged illness causes longer hospital stays, the need for more expensive drugs, and financial difficulties for those affected. In 2015, the WHO launched the global antimicrobial resistance and use surveillance system, which combined data from AMR surveillance in humans and antimicrobial drug use surveillance. GLASS offers a standardized approach to data collection, analysis, interpretation, and sharing by countries, territories, and areas, as well as monitoring the state of existing and new national surveillance systems.
Restraints
High Cost of Deployment for Small Healthcare Organizations
The rising price of interoperability and deployment makes implementing healthcare IT software solutions expensive. Smaller healthcare companies encounter difficulty in deploying internet access due to difficulties in setting up numerous networks in healthcare contexts, limited wireless possibilities, and the requirement for comprehensive security procedures to prevent data breaches. Also, infection surveillance software is costly. Furthermore, support and maintenance services, which include software modification and upgrading in response to changing user requirements, are recurring expenses that make for a significant portion of the total cost of ownership. Additionally, custom interface development for post-sales device connection necessitates additional validation and verification, increasing the total cost of ownership for healthcare providers. These additional fees are prohibitively expensive for smaller hospitals and healthcare organizations.
Impact of COVID-19 on Global Infection Surveillance Solutions Market
COVID-19 had a detrimental impact on infection surveillance solutions market. The pandemic compelled governments to invest extensively in vaccination efforts as well as hospital facilities and staffing. Yet, the global economic slump has upended government intentions to maintain or grow spending to address a backlog of non-COVID treatment and resolve staffing shortages. According to the Economist Intelligence Unit, total healthcare spending will rise by 4.9% in nominal terms in 2023, owing to higher expenses and wages. Yet, actual spending is anticipated to fall somewhat as it fails to keep up with inflation.
Global Infection Surveillance Solutions Market
Segmental Coverage
Global Infection Surveillance Solutions Market – By Offering
By offering, global infection surveillance solutions market is bifurcated into Software and Services segments. The software segment is expected to hold a higher share in global infection surveillance solutions market during the forecast period, because of the increasing use of management surveillance software. The software segment includes on-premises and web-based. During the period in analysis, the web-based software is expected to grow at a faster rate. The rise in sub-segment can be ascribed to its advantages over on-premises software, including as availability in various configurations, rapid return on investment, and real-time analysis. Furthermore, healthcare IT businesses develop unique solutions in data management, analytics, and infrastructure that facilitate the collecting of data from electronic health records (EHR), infection, and epidemic patterns via their software packages.
Global Infection Surveillance Solutions Market – By Infection
Based on infection, global infection surveillance solutions market is divided into Surgical Site Infections (SSI), Blood Stream Infections (BSI), and Urinary Tract Infections (UTI). The surgical site infections segment is expected to dominate the market during the period in analysis due to growing incidence of surgical site infection. The urinary tract infection (UTI) segment held the second highest market share in 2022 and is likely to continue to maintain its position. According to statistics given by womenshealth.gov, women are 30% more prone to UTI than men. Furthermore, the CDC reports that 75% of UTIs acquired in hospitals are the result of extended usage of urinary catheters. Furthermore, the European Institute for Disease Prevention and Control reports that 3% of all patients treated in ICU for more than two days had UTIs.
Global Infection Surveillance Solutions Market – By End Use
Based on end use, global infection surveillance solutions market is divided into Long Term Care Facilities, Hospitals, and other segments (Clinics and Ambulatory Surgical Centers). The hospital segment held the highest market share and is expected to make substantial improvement throughout the forecast period. The increased burden of infectious and chronic health diseases has led in an increase in the number of people requiring frequent hospitalizations, resulting in a significant increase in hospital-acquired infections and associated healthcare expense. This has increased demand for improved healthcare infrastructure, leading in the development of new hospitals and healthcare facilities, which has improved the industry's outlook.
Global Infection Surveillance Solutions Market – By Region
Global infection surveillance solutions market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest market share. The region's massive market is mostly attributable to rising R&D activity in the medical sciences. Health and Human Services (HHS), which is overseen by the cabinet-level agency of the US federal government, is particularly liberal in sponsoring and maintaining technology research in medical sciences. According to studies, one out of every 25 hospitalized patients in the United States suffers from HAI. Hospitals are struggling to reduce infection rates because many of these infections originate in the intensive care unit (ICU). Furthermore, rising healthcare costs in the US are prompting individual hospitals to relocate or integrate with independent healthcare groups to form larger healthcare systems that can widen their service reach, leverage economies of scale, and withstand increasing regulatory pressures from the current government. These dynamics are driving the advancement of technology innovations in the hospital, which in turn boosts the market for infection surveillance systems.
Competitive Landscape
Major players operating in global infection surveillance solutions market include Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., and IBM Corporation (Truven Health Analytics). To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In June 2019- GOJO Industries, Inc. unveiled a new solution that uses Bluetooth Low Energy (BLE) technology to capture healthcare worker-specific hand hygiene events in real time.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Million |
Market Coverage |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Product/ Service Segmentation |
Offering, Infection Type, End Use, Region |
Key Players |
Cerner Corporation, Epic Systems Corporation, VigiLanz Corporation, Becton, Dickinson and Company, Premier Inc., DEB Group Ltd, RL Solutions, Baxter International Inc. (ICNet International), Gojo Industries Inc., IBM Corporation (Truven Health Analytics) |
By Offering
-
Software
-
Services
By Infection Type
-
Surgical Site Infections (SSI)
-
Blood Stream Infections (BSI)
-
Urinary Tract Infections (UTI)
By End Use
-
Long Term Care Facilities
-
Hospitals
By Region
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East and Africa
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Infection Surveillance Solutions Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Growing Adoption of Antimicrobial Stewardship Programs
- Increasing Automotive and Transportation Industry
- Restraints
- High Cost of Deployment for Small Healthcare Organizations
- Privacy and Security Concerns
- Opportunities
- Growing incidences of Healthcare-Associated Infections (HAIs) Driving Demand for Infection Surveillance Solutions
- Challenges
- Limited Awareness and Education
- Growth Drivers
- Technology Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Infection Surveillance Solutions Market Overview
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- Software
- On-premises
- Web-based
- Services
- Maintenance and Support
- Consultation and Training
- Implementation Service
- Software
- By Infection Type
- Surgical Site Infections (SSI)
- Blood Stream Infections (BSI)
- Urinary Tract Infections (UTI)
- Others
- By End Use
- Long Term Care Facilities
- Hospitals
- Others (Clinics, Ambulatory Surgical Centers)
- By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
- By Offering
- Market Size & Forecast, 2019–2029
- North America Infection Surveillance Solutions Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- By Infection Type
- By End Use
- By Country
- US
- By Offering
- By Infection Type
- By End Use
- Canada
- By Offering
- By Infection Type
- By End Use
- US
- Market Size & Forecast, 2019–2029
- Europe Infection Surveillance Solutions Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- By Infection Type
- By End Use
- By Country
- Germany
- UK
- By Offering
- By Infection Type
- By End Use
- Italy
- By Offering
- By Infection Type
- By End Use
- France
- By Offering
- By Infection Type
- By End Use
- Spain
- By Offering
- By Infection Type
- By End Use
- The Netherlands
- By Offering
- By Infection Type
- By End Use
- Rest of Europe
- By Offering
- By Infection Type
- By End Use
- Market Size & Forecast, 2019–2029
- Asia-Pacific Infection Surveillance Solutions Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- By Infection Type
- By End Use
- By Country
- China
- By Offering
- By Infection Type
- By End Use
- India
- By Offering
- By Infection Type
- By End Use
- Japan
- By Offering
- By Infection Type
- By End Use
- South Korea
- By Offering
- By Infection Type
- By End Use
- Australia & New Zealand
- By Offering
- By Infection Type
- By End Use
- Indonesia
- By Offering
- By Infection Type
- By End Use
- Malaysia
- By Offering
- By Infection Type
- By End Use
- Singapore
- By Offering
- By Infection Type
- By End Use
- Philippines
- By Offering
- By Infection Type
- By End Use
- Vietnam
- By Offering
- By Infection Type
- By End Use
- Rest of APAC
- By Offering
- By Infection Type
- By End Use
- China
- Market Size & Forecast, 2019–2029
- Latin America Infection Surveillance Solutions Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- By Infection Type
- By End Use
- By Country
- Brazil
- By Offering
- By Infection Type
- By End Use
- Mexico
- By Offering
- By Infection Type
- By End Use
- Argentina
- By Offering
- By Infection Type
- By End Use
- Peru
- By Offering
- By Infection Type
- By End Use
- Rest of LATAM
- By Offering
- By Infection Type
- By End Use
- Brazil
- Market Size & Forecast, 2019–2029
- Middle East & Africa Infection Surveillance Solutions Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Offering
- By Infection Type
- By End Use
- By Country
- Saudi Arabia
- By Offering
- By Infection Type
- By End Use
- UAE
- By Offering
- By Infection Type
- By End Use
- Qatar
- By Offering
- By Infection Type
- By End Use
- Kuwait
- By Offering
- By Infection Type
- By End Use
- South Africa
- By Offering
- By Infection Type
- By End Use
- Nigeria
- By Offering
- By Infection Type
- By End Use
- Algeria
- By Offering
- By Infection Type
- By End Use
- Rest of MEA
- By Offering
- By Infection Type
- By End Use
- Saudi Arabia
- Market Size & Forecast, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Infection Surveillance Solutions Company Market Share Analysis, 2022
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Covid-19 on Global Infection Surveillance Solutions Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- Cerner Corporation
- Epic Systems Corporation
- VigiLanz Corporation
- Becton, Dickinson and Company
- Premier Inc.
- DEB Group Ltd
- RL Solutions
- Baxter International Inc. (ICNet International)
- Gojo Industries Inc.
- IBM Corporation (Truven Health Analytics)
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Global Infection Surveillance Solutions Segmentation
Figure 2 Global Infection Surveillance Solutions Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Global Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 5 Global Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 6 Global Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 7 Global Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 8 Global Infection Surveillance Solutions Market Share, By Region, By Value, 2019–2029
Figure 9 North America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 10 North America Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 11 North America Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 12 North America Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 13 North America Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029
Figure 14 US Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 15 US Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 16 US Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 17 US Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 18 Canada Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 19 Canada Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 20 Canada Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 21 Canada Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 22 Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 23 Europe Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 24 Europe Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 25 Europe Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 26 Europe Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029
Figure 27 Germany Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 28 Germany Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 29 Germany Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 30 Germany Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 31 UK Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 32 UK Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 33 UK Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 34 UK Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 35 Italy Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 36 Italy Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 37 Italy Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 38 Italy Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 39 France Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 40 France Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 41 France Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 42 France Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 43 Spain Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 44 Spain Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 45 Spain Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 46 Spain Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 47 The Netherlands Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 48 The Netherlands Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 49 The Netherlands Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 50 The Netherlands Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 51 Rest of Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 52 Rest of Europe Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 53 Rest of Europe Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 54 Rest of Europe Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 55 Asia-Pacific Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 56 Asia-Pacific Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 57 Asia-Pacific Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 58 Asia-Pacific Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 59 Asia-Pacific Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029
Figure 60 China Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 61 China Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 62 China Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 63 China Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 64 India Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 65 India Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 66 India Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 67 India Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 68 Japan Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 69 Japan Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 70 Japan Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 71 Japan Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 72 South Korea Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 73 South Korea Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 74 South Korea Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 75 South Korea Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 76 Australia & New Zealand Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 77 Australia & New Zealand Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 78 Australia & New Zealand Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 79 Australia & New Zealand Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 80 Indonesia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 81 Indonesia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 82 Indonesia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 83 Indonesia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 84 Malaysia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 85 Malaysia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 86 Malaysia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 87 Malaysia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 88 Singapore Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 89 Singapore Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 90 Singapore Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 91 Singapore Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 92 Philippines Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 93 Philippines Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 94 Philippines Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 95 Philippines Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 96 Vietnam Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 97 Vietnam Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 98 Vietnam Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 99 Vietnam Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 100 Rest of APAC Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 101 Rest of APAC Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 102 Rest of APAC Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 103 Rest of APAC Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 104 Latin America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 105 Latin America Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 106 Latin America Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 107 Latin America Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 108 Latin America Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029
Figure 109 Brazil Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 110 Brazil Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 111 Brazil Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 112 Brazil Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 113 Mexico Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 114 Mexico Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 115 Mexico Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 116 Mexico Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 117 Argentina Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 118 Argentina Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 119 Argentina Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 120 Argentina Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 121 Peru Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 122 Peru Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 123 Peru Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 124 Peru Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 125 Rest of LATAM Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 126 Rest of LATAM Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 127 Rest of LATAM Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 128 Rest of LATAM Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 129 Middle East & Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 130 Middle East & Africa Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 131 Middle East & Africa Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 132 Middle East & Africa Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 133 Middle East & Africa Infection Surveillance Solutions Market Share, By Country, By Value, 2019–2029
Figure 134 Saudi Arabia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 135 Saudi Arabia Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 136 Saudi Arabia Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 137 Saudi Arabia Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 138 UAE Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 139 UAE Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 140 UAE Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 141 UAE Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 142 Qatar Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 143 Qatar Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 144 Qatar Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 145 Qatar Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 146 Kuwait Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 147 Kuwait Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 148 Kuwait Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 149 Kuwait Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 150 South Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 151 South Africa Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 152 South Africa Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 153 South Africa Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 154 Nigeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 155 Nigeria Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 156 Nigeria Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 157 Nigeria Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 158 Algeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 159 Algeria Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 160 Algeria Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 161 Algeria Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
Figure 162 Rest of MEA Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Figure 163 Rest of MEA Infection Surveillance Solutions Market Share, By Offering, By Value, 2019–2029
Figure 164 Rest of MEA Infection Surveillance Solutions Market Share, By Infection Type, By Value, 2019–2029
Figure 165 Rest of MEA Infection Surveillance Solutions Market Share, By End Use, By Value, 2019–2029
List of Tables
Table 1 Global Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 2 Global Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 3 Global Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 4 Global Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 5 Global Infection Surveillance Solutions Market Size, By Region, By Value, 2019–2029
Table 6 North America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 7 North America Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 8 North America Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 9 North America Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 10 North America Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029
Table 11 US Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 12 US Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 13 US Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 14 US Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 15 Canada Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 16 Canada Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 17 Canada Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 18 Canada Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 19 Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 20 Europe Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 21 Europe Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 22 Europe Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 23 Europe Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029
Table 24 Germany Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 25 Germany Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 26 Germany Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 27 Germany Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 28 UK Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 29 UK Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 30 UK Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 31 UK Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 32 Italy Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 33 Italy Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 34 Italy Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 35 Italy Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 36 France Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 37 France Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 38 France Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 39 France Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 40 Spain Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 41 Spain Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 42 Spain Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 43 Spain Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 44 The Netherlands Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 45 The Netherlands Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 46 The Netherlands Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 47 The Netherlands Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 48 Rest of Europe Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 49 Rest of Europe Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 50 Rest of Europe Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 51 Rest of Europe Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 52 Asia-Pacific Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 53 Asia-Pacific Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 54 Asia-Pacific Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 55 Asia-Pacific Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 56 Asia-Pacific Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029
Table 57 China Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 58 China Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 59 China Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 60 China Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 61 India Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 62 India Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 63 India Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 64 India Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 65 Japan Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 66 Japan Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 67 Japan Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 68 Japan Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 69 South Korea Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 70 South Korea Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 71 South Korea Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 72 South Korea Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 73 Australia & New Zealand Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 74 Australia & New Zealand Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 75 Australia & New Zealand Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 76 Australia & New Zealand Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 77 Indonesia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 78 Indonesia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 79 Indonesia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 80 Indonesia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 81 Malaysia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 82 Malaysia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 83 Malaysia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 84 Malaysia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 85 Singapore Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 86 Singapore Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 87 Singapore Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 88 Singapore Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 89 Philippines Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 90 Philippines Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 91 Philippines Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 92 Philippines Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 93 Vietnam Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 94 Vietnam Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 95 Vietnam Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 96 Vietnam Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 97 Rest of APAC Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 98 Rest of APAC Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 99 Rest of APAC Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 100 Rest of APAC Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 101 Latin America Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 102 Latin America Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 103 Latin America Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 104 Latin America Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 105 Latin America Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029
Table 106 Brazil Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 107 Brazil Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 108 Brazil Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 109 Brazil Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 110 Mexico Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 111 Mexico Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 112 Mexico Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 113 Mexico Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 114 Argentina Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 115 Argentina Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 116 Argentina Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 117 Argentina Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 118 Peru Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 119 Peru Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 120 Peru Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 121 Peru Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 122 Rest of LATAM Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 123 Rest of LATAM Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 124 Rest of LATAM Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 125 Rest of LATAM Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 126 Middle East & Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 127 Middle East & Africa Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 128 Middle East & Africa Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 129 Middle East & Africa Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 130 Middle East & Africa Infection Surveillance Solutions Market Size, By Country, By Value, 2019–2029
Table 131 Saudi Arabia Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 132 Saudi Arabia Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 133 Saudi Arabia Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 134 Saudi Arabia Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 135 UAE Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 136 UAE Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 137 UAE Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 138 UAE Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 139 Qatar Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 140 Qatar Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 141 Qatar Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 142 Qatar Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 143 Kuwait Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 144 Kuwait Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 145 Kuwait Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 146 Kuwait Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 147 South Africa Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 148 South Africa Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 149 South Africa Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 150 South Africa Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 151 Nigeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 152 Nigeria Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 153 Nigeria Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 154 Nigeria Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 155 Algeria Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 156 Algeria Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 157 Algeria Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 158 Algeria Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 159 Rest of MEA Infection Surveillance Solutions Market Size, By Value (USD Million), 2019–2029
Table 160 Rest of MEA Infection Surveillance Solutions Market Size, By Offering, By Value, 2019–2029
Table 161 Rest of MEA Infection Surveillance Solutions Market Size, By Infection Type, By Value, 2019–2029
Table 162 Rest of MEA Infection Surveillance Solutions Market Size, By End Use, By Value, 2019–2029
Table 163 Citigroup Inc. Company Overview
Table 164 Citigroup Inc. Financial Overview
Table 165 JPMorgan Chase & Co. Company Overview
Table 166 JPMorgan Chase & Co. Financial Overview
Table 167 Wells Fargo & Company Overview
Table 168 Wells Fargo & Company Financial Overview
Table 169 Bank of America Corporation Company Overview
Table 170 Bank of America Corporation Financial Overview
Table 171 American Express Company Overview
Table 172 American Express Company Financial Overview
Table 173 HSBC Holdings plc Company Overview
Table 174 HSBC Holdings plc Financial Overview
Table 175 Industrial and Commercial Bank of China Company Overview
Table 176 Industrial and Commercial Bank of China Financial Overview
Table 177 U.S. Bancorp Company Overview
Table 178 U.S. Bancorp Financial Overview
Table 179 BNP Paribas, Company Overview
Table 180 BNP Paribas, Financial Overview
Table 181 TD Bank, N.A. Company Overview
Table 182 TD Bank, N.A. Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.